Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

BACKGROUND: The Systolic Blood Pressure Intervention Trial (SPRINT) showed that targeting a systolic blood pressure (SBP) of ≤ 120 mm Hg (intensive treatment) reduced cardiovascular disease (CVD) events compared to SBP of ≤ 140 mm Hg (standard treatment); however, it is unclear if this effect is sim...

Descripción completa

Detalles Bibliográficos
Autores principales: Still, Carolyn H, Rodriguez, Carlos J, Wright, Jackson T, Craven, Timothy E, Bress, Adam P, Chertow, Glenn M, Whelton, Paul K, Whittle, Jeffrey C, Freedman, Barry I, Johnson, Karen C, Foy, Capri G, He, Jiang, Kostis, John B, Lash, James P, Pedley, Carolyn F, Pisoni, Roberto, Powell, James R, Wall, Barry M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861531/
https://www.ncbi.nlm.nih.gov/pubmed/28985268
http://dx.doi.org/10.1093/ajh/hpx138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861531/
https://www.ncbi.nlm.nih.gov/pubmed/28985268
http://dx.doi.org/10.1093/ajh/hpx138

Ejemplares similares